AERIFY-1 study met its primary endpoint of a statistically significant reduction in moderate or severe exacerbations in former smokers regardless of eosinophilic phenotype and provided a clinically ...

Please provide your email address to receive an email when new articles are posted on . The odds for moderate exacerbations went down by 60% per one standard deviation rise in two omega-3 fatty acids.

No causal association with psychiatric disorders was observed in patients with chronic obstructive pulmonary disease (COPD) without a smoking history, while ever ...

Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel, discusses the potential of tailored treatment strategies and the importance of smoking cessation. It is important ...

BOSTON--(BUSINESS WIRE)--A new research study on chronic obstructive pulmonary disease (COPD) is now available in the Greater Houston, Texas, area for a potential treatment for reducing COPD ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Factors included smoking status, cigarette ...

Miami (March 13, 2025) – For current and former smokers, statins may reduce the amount of chest muscle loss, while aspirin may contribute to increased chest muscle loss, according to a new study. The ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Bronchiectasis ...

BOSTON--(BUSINESS WIRE)--A new research study on chronic obstructive pulmonary disease (COPD) is now available in Mooresville, N.C., for a potential treatment for reducing COPD exacerbations. The ...